Department of Botany, Islamia College, Peshawar, Pakistan.
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Umm Al-Qura University, Makkah Almukkarramah, Saudi Arabia.
Curr Pharm Des. 2021;27(13):1564-1578. doi: 10.2174/1381612826666201202125807.
Cannabis sativa is a well-known plant that has been recognized for its benefits since ancient times by several medicinal systems, including those of China, India, Greece, and Egypt. Although C. sativa is one of the most investigated medicinal plants in the world, it faces some of the greatest controversies surrounding its legalization and use as a medication. C. sativa contains several hundred phytoconstituents, including the infamous "cannabinoids". It is necessary to properly understand the medicinal importance of these phytochemicals and spread awareness among the countries where cannabis is still facing legal obstacles. The current review focuses on the most recent literature pertaining to various applications of cannabinoids, with a special focus on the medicinal aspect of these phytochemicals. Peer-reviewed articles focusing on the importance of cannabis and cannabinoids are the target of this review. Articles were selected based on the relevance to the general scope of the work, i.e., application of cannabinoids. Cannabinoids can truly be regarded as wonder drugs, considering their immense diversity of usage. Unfortunately, however, many of the mares have never been researched biologically or pharmacologically due to their low yield in the plant. However, the approval of some cannabinoids by the FDA (along with other recognized national medical health systems) has opened the horizon for the use of these natural drugs in medicines such as Epidiolex® (cannabidiol, used for the treatment of severe forms of epilepsy) and Sativex®(Δ-tetrahydrocannabinol and cannabidiol, used for the treatment of spasticity caused by multiple sclerosis). Many pharmacological properties of C. sativa are attributed to cannabidiol (CBD), a non-psychoactive component, along with Δ9-tetrahydrocannabinol (Δ-THC), a psychoactive component. This review addresses the most important applications or current utilization of cannabinoids in a variety of treatments such as chronic pain, cancer, emesis, anorexia, irritable bowel syndrome, communicable diseases, glaucoma, and central nervous system disorders. The biosynthetic pathway of cannabinoids is also discussed. In short, cannabis has a myriad of bioactive compounds that have the potential to increase the list of approved cannabinoids suitable for therapy.
大麻是一种广为人知的植物,自古以来就被包括中国、印度、希腊和埃及在内的几种医学体系所认可。尽管大麻是世界上研究最多的药用植物之一,但它在合法化和作为药物使用方面面临着一些最大的争议。大麻含有数百种植物化学物质,包括臭名昭著的“大麻素”。有必要正确理解这些植物化学物质的药用重要性,并在大麻仍面临法律障碍的国家提高认识。本综述重点关注大麻素的最新文献,特别关注这些植物化学物质的药用方面。本文综述了以大麻和大麻素为重点的、经过同行评审的文章。选择的文章主要基于与工作的一般范围(即大麻素的应用)相关的重要性。考虑到大麻素的用途非常广泛,它们确实可以被视为神奇药物。然而,由于其在植物中的产量低,许多马前卒在生物学或药理学上从未得到研究。然而,一些大麻素获得 FDA(以及其他公认的国家医疗保健系统)的批准,为这些天然药物在药物中的使用开辟了道路,例如 Epidiolex®(用于治疗严重癫痫)和 Sativex®(Δ-四氢大麻酚和大麻二酚,用于治疗多发性硬化症引起的痉挛)。大麻的许多药理学特性归因于大麻素(CBD),一种非精神活性成分,以及Δ9-四氢大麻酚(Δ-THC),一种精神活性成分。本综述介绍了大麻素在各种治疗中的最重要应用或当前利用,如慢性疼痛、癌症、呕吐、厌食症、肠易激综合征、传染病、青光眼和中枢神经系统疾病。还讨论了大麻素的生物合成途径。简而言之,大麻具有多种生物活性化合物,有可能增加适合治疗的批准大麻素的清单。